140 related articles for article (PubMed ID: 19594)
21. Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment.
Fuller RW; Snoddy HD
Pharmacol Biochem Behav; 1979 Apr; 10(4):561-3. PubMed ID: 572552
[TBL] [Abstract][Full Text] [Related]
22. Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine.
Fuller RW; Hemrick-Luecke SK
Neuropharmacology; 1982 May; 21(5):433-8. PubMed ID: 7110533
[TBL] [Abstract][Full Text] [Related]
23. The effects of different amphetamines on copulatory behaviour and stereotype activity in the female rat, after treatment with monoamine depletors and synthesis inhibitors.
Michanek A; Meyerson BJ
Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):301-12. PubMed ID: 145834
[TBL] [Abstract][Full Text] [Related]
24. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
[No Abstract] [Full Text] [Related]
25. Antagonism of methylphenidate-induced stereotyped gnawing in mice.
Pedersen V; Christensen AV
Acta Pharmacol Toxicol (Copenh); 1972; 31(5):488-96. PubMed ID: 4678829
[No Abstract] [Full Text] [Related]
26. A study of the role of catecholamines in the response to various central stimulants.
Sayers AC; Handley SL
Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
[No Abstract] [Full Text] [Related]
27. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
Braestrup C; Andersen H; Randrup A
Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
[TBL] [Abstract][Full Text] [Related]
28. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
Afanas'ev II; Dvorkina ML; Raevskiĭ KS
Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
[TBL] [Abstract][Full Text] [Related]
29. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
Kanzaki A; Akiyama K; Otsuki S
Brain Res; 1992 Jan; 569(2):181-8. PubMed ID: 1371707
[TBL] [Abstract][Full Text] [Related]
30. Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats.
Clemens JA; Fuller RW
Life Sci; 1979 May; 24(22):2077-81. PubMed ID: 459703
[No Abstract] [Full Text] [Related]
31. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
32. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
Martin-Iverson MT; Yamada N; By AW; Lodge BA
J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
[TBL] [Abstract][Full Text] [Related]
33. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
Miller HH; Shore PA
Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
35. The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm.
Hiroi N; White NM
Brain Res; 1990 Feb; 510(1):33-42. PubMed ID: 2322845
[TBL] [Abstract][Full Text] [Related]
36. Relationship of biogenic amines to behavior.
Breese GR; Cooper BR; Hollister AS
J Psychiatr Res; 1974; 11():125-33. PubMed ID: 4282384
[No Abstract] [Full Text] [Related]
37. MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats.
Hemrick-Luecke SK; Henderson MG; Fuller RW
Life Sci; 1992; 50(6):PL31-3. PubMed ID: 1734157
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.
Bouhayat S; Piessard S; Le Baut G; Sparfel L; Petit JY; Piriou F; Welin L
J Med Chem; 1985 May; 28(5):555-9. PubMed ID: 4039368
[TBL] [Abstract][Full Text] [Related]
39. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
Chiueh CC; Moore KE
J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
[TBL] [Abstract][Full Text] [Related]
40. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine.
Callaway CW; Kuczenski R; Segal DS
Brain Res; 1989 Dec; 505(1):83-90. PubMed ID: 2611681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
